Fuso Pharmaceutical Industries,Ltd. Statistics
Want to see JP:4538 full AI Analyst Report?
Fuso Pharmaceutical Industries,Ltd. (4538) Stock Statistics & Valuation Metrics
Total Valuation
Fuso Pharmaceutical Industries,Ltd. has a market cap or net worth of JPY 19.25B. The enterprise value is JPY 36.68B.
- Market Cap
- JPY 19.25B
- Enterprise Value
- JPY 36.68B
Share Statistics
Fuso Pharmaceutical Industries,Ltd. has 9,451,169 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 9,451,169
- Owned by Insiders
- ―
- Owned by Institutions
- 1.73%
Financial Efficiency
Fuso Pharmaceutical Industries,Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 3.34%.
- Return on Equity (ROE)
- 0.06
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 3.34%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 45.48M
- Profits Per Employee
- 1.47M
- Employee Count
- 1,370
- Asset Turnover
- 0.69
- Inventory Turnover
- 2.95
Valuation Ratios
The current PE Ratio of Fuso Pharmaceutical Industries,Ltd. is 8.33. Fuso Pharmaceutical Industries,Ltd.’s PEG ratio is 0.05.
- PE Ratio
- 8.33
- PS Ratio
- 0.29
- PB Ratio
- 0.51
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 0.05
Income Statement
In the last 12 months, Fuso Pharmaceutical Industries,Ltd. had revenue of 62.31B and earned 2.01B in profits. Earnings per share was 235.52.
- Revenue
- 62.31B
- Gross Profit
- 15.99B
- Operating Income
- 2.64B
- Pretax Income
- 2.44B
- Net Income
- 2.01B
- EBITDA
- 5.38B
- Earnings Per Share (EPS)
- 235.52
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Fuso Pharmaceutical Industries,Ltd. pays an annual dividend of JPY 45.00, resulting in a dividend yield of 4.10%
- Dividend Per Share
- JPY 45.00
- Dividend Yield
- 4.10%
- Payout Ratio
- 35.79%
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 12.00%
Stock Price Statistics
- Beta
- 0.51
- 52-Week Price Change
- -0.05%
- 50-Day Moving Average
- 2152.45
- 200-Day Moving Average
- 2174.49
- Relative Strength Index (RSI)
- 60.86
- Average Volume (3m)
- 20.50K
Important Dates
Fuso Pharmaceutical Industries,Ltd. upcoming earnings date is Feb 11, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 11, 2026
- Next Earnings Date
- Feb 11, 2027
- Ex-Dividend Date
- Mar 30, 2026
Financial Position
Fuso Pharmaceutical Industries,Ltd. as a current ratio of 1.11, with Debt / Equity ratio of 81.19%
- Current Ratio
- 1.11
- Quick Ratio
- 0.81
- Debt to Market Cap
- 1.41
- Net Debt to EBITDA
- 4.39
- Interest Coverage Ratio
- 8.05
Taxes
In the past 12 months, Fuso Pharmaceutical Industries,Ltd. has paid 426.00M in taxes.
- Income Tax
- 426.00M
- Effective Tax Rate
- 0.17
Enterprise Valuation
Fuso Pharmaceutical Industries,Ltd. EV to EBITDA ratio is 6.32, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.57
- EV to EBITDA
- 6.32
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Fuso Pharmaceutical Industries,Ltd. has JPY 4.57B in cash and marketable securities with JPY 26.31B in debt, giving a net cash position of -JPY 21.74B billion.
- Cash & Marketable Securities
- JPY 4.57B
- Total Debt
- JPY 26.31B
- Net Cash
- -JPY 21.74B
- Net Cash Per Share
- -JPY 2,299.93
- Tangible Book Value Per Share
- JPY 4,036.27
Margins
Gross margin is 25.40%, with operating margin of 4.94%, and net profit margin of 3.50%.
- Gross Margin
- 25.40%
- Operating Margin
- 4.94%
- Pretax Margin
- 4.36%
- Net Profit Margin
- 3.50%
- EBITDA Margin
- 9.06%
- EBIT Margin
- 5.14%
Analyst Forecast
The average price target for Fuso Pharmaceutical Industries,Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 2.29%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- ―
- AI Score
- 63

